Annals of Oncology Advance Access originally published online on June 2, 2005
Annals of Oncology 2005 16(7):995-996; doi:10.1093/annonc/mdi230
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2005 European Society for Medical Oncology
Editorial |
Evolving imaging technology: contrast-enhanced Doppler ultrasound is early and rapid predictor of tumour response
Erasmus MC-Daniel den Hoed Cancer Center, 301 Groene Hilledijk, 3075 EA Rotterdam, The Netherlands
Email: a.m.m.eggermont@erasmusmc.nl
| The first 10% of the full text of this article appears below. |
The article by Lassau et al. [1
] on the use of contrast-enhanced Doppler ultrasound (Doppler US) for early and rapid assessment of tumour response after isolated limb perfusion (ILP) for locally advanced soft tissue sarcomas (STSs) of the extremities is an excellent example of the new opportunities that arise with rapidly evolving technologies in imaging. In the quest for early predictors and surrogate markers for response this technology represents a relatively simple, practical and cheap procedure.
In view of the large number of new drugs and